InvestorsHub Logo
Followers 69
Posts 5129
Boards Moderated 0
Alias Born 05/25/2021

Re: saxxie2 post# 661966

Saturday, 01/06/2024 2:07:26 PM

Saturday, January 06, 2024 2:07:26 PM

Post# of 726520
This has nothing to do with DCVax-L. Note that it is the technology developed by Roswell Park Cancer Institute. If I remember correctly, the technology triggers immune system to attack tumor blood vessels. They used the technology for GBM trial. I don't recall patients survived three years.

Have you wondered why the similar collaboration trial between NWBO and Merck disappeared in radar?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News